Katherine Stueland - 15 Mar 2026 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Bridget Brown, Attorney-in-Fact
Issuer symbol
WGS
Transactions as of
15 Mar 2026
Net transactions value
-$1,319,291
Form type
4
Filing time
17 Mar 2026, 18:40:58 UTC
Previous filing
11 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stueland Katherine CHIEF EXECUTIVE OFFICER, Director C/O GENEDX HOLDINGS CORP., 333 LUDLOW ST., NORTH TOWER, 6TH FLOOR, STAMFORD /s/ Bridget Brown, Attorney-in-Fact 17 Mar 2026 0001689575

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WGS Class A Common Stock Options Exercise +11,921 +27% $0.000000* 56,876 15 Mar 2026 Direct F1
transaction WGS Class A Common Stock Options Exercise +18,750 +33% $0.000000* 75,626 16 Mar 2026 Direct F1
transaction WGS Class A Common Stock Sale $548,035 -7,178 -9.5% $76.35 68,448 16 Mar 2026 Direct F2, F3
transaction WGS Class A Common Stock Sale $711,090 -9,229 -13% $77.05 59,219 16 Mar 2026 Direct F2, F4
transaction WGS Class A Common Stock Sale $60,166 -772 -1.3% $77.94 58,447 16 Mar 2026 Direct F2, F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WGS Restricted Stock Unit Options Exercise -11,921 -25% $0.000000* 35,763 15 Mar 2026 Class A Common Stock 11,921 Direct F1, F7
transaction WGS Restricted Stock Unit Options Exercise -18,750 -20% $0.000000* 75,000 16 Mar 2026 Class A Common Stock 18,750 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
F2 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.735 to $76.73 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 5 of this Form 4.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.74 to $77.71 per share, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.75 to $78.16 per share, inclusive.
F6 Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 58,447 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 414,695 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms.
F7 25% of the award vested or vests annually on the anniversary of the grant date, with the first tranche vested on March 15, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.
F8 6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date.